Synopsis
Since
its introduction in 1990's, ASL has gone through
abundant developments that have remarkably improved this contrast-material-free
technique in data acquisition, image quality, and quantitative modeling. We now
have a variety of methods to choose from and a number of review articles to refer to. However, it still seems an open question
when it comes to the usefulness of ASL in brain mapping. In this presentation,
the issues that have been keeping us from saying yes to the question will be reviewed.
The usefulness and caveats of ASL in brain mapping will be discussed from the
viewpoint of clinical application.
Introduction
Since its introduction in 1990’s (1-3), arterial
spin labeling (ASL) has gone through abundant developments that have remarkably
improved this contrast-material-free technique in data acquisition, image quality,
and quantitative modeling. We now have a variety of methods to choose from and
a number of review articles (4-6) including
a recently published white paper (7) to refer to. However, it still seems an open question when it comes
to the usefulness of ASL in brain mapping. In this presentation, the issues
that have been keeping us from saying yes to the question will be reviewed. The
usefulness and caveats of ASL in brain mapping will be discussed from the
viewpoint of clinical application.Caveats
Absolute
quantification of ASL signal requires knowledge of several parameters. Among
these, arterial transit time (ATT) is arguably the most explored, probably
because it is usually unknown in practice and even harder to predict in disease
conditions. Not knowing ATT makes it difficult to choose the time delay between
label and excitation pulses which is commonly called post-labeling delay (PLD) in
continuous labeling methods and inversion time (TI) in pulsed labeling methods.
In theory, the optimal PLD/TI is equal to ATT. If PLD/TI is shorter than ATT,
there will be intravascular signal that cannot be quantified as perfusion and delayed
flow will be misinterpreted as low flow or no flow. To avoid these, one may set
PLD/TI as long as possible. However, the longer PLD/TI, the more
signal-to-noise (SNR) we lose and measurement reliability starts being
compromised when SNR drops below some threshold. Multiple PLD/TI’s can be used
to fit for ATT (8) but how to choose these PLD/TI’s still relies on
knowledge of ATT because these PLD/TI’s need to cover the wash-in phase and if
possible also the wash-out phase. The question is, however, if we know how to
choose these PLD/TI’s, we kind of already know about the ATT. And let’s not
forget that this increases the total scan time. For a fixed scan time, this
means we have to divide it into multiple PLD/TI scans, which means fewer
measurements and thus lower SNR for each PLD/TI scan. How would this impact the
reliability of the fitted ATT? Not to mention other factors such as spin
compartment (9) (does the arterial spin stay in blood stream all the
time? or does it enter the interstitial space at some time? This affects the
choice of relaxation time constants), labeling efficiency (10), and relaxation time constants. Is it possible to
deal with all these issues on a per-subject and per-exam basis?Applications
Enough
being said about quantification, we wonder if ASL is only useful when it is
absolutely quantitative. Fortunately, multiple parameters can be derived from
ASL even though they may not be quantitative. For example, ATT can be estimated
by using multi-PLD/TI ASL. Even though the calculated transit time may not be perfectly accurate, it would be useful enough to highlight the area with abnormal
changes. This is also true with the global perfusion derived from single-PLD/TI
ASL. Even though the perfusion value may not be absolutely quantitative, local
increase/decrease or intravascular hyperintensities in contrast to
normal/contralateral areas may provide useful information. Furthermore, ASL can
be tailored to be vessel selective/encoding to depict arterial flow territories
(11). Information of how arterial blood is distributed to
perfusion territories may help the evaluation of collateral circulation (12,13). Another application of ASL that is not related to
absolute quantification is for calibrated blood-oxygenation-level-dependent
(BOLD) MRI (14,15), an application starting to gather attention in
clinical neurology and neuroscience. Briefly, relative cerebral blood flow
change is measured along with relative BOLD signal change. The measurement is
first performed to estimate the constant of maximum signal change or ceiling
effect in an iso-CMRO2 (CMRO2 = cerebral metabolic rate
of oxygen) session where changes of cerebral blood flow and BOLD signal are
induced (e.g., by hypercapnia) without altering CMRO2. After the
calibration, task-specific CMRO2 demand can be calculated by using
the ceiling effect constant and simultaneous measurement of ASL and BOLD
signals.Summary
So,
is ASL useful in brain mapping? I think we should first acknowledge that ASL is
not a magic technique that works in every possible way, which is probably true
with all other MR techniques. If a ‘yes’ or ‘no’ is really demanded, my
personal opinion is more of yes. ASL definitely has its niche in brain mapping but
this does not mean it is the first choice in all applications. Sophisticated data
acquisition and quantitative modeling should be considered in the context of SNR
achievable with clinically reasonable scan time.Acknowledgements
Grant sponsor: Ministry of Science and Technology, Taiwan. Grant numbers: 105-2314-B-002 -094 -MY3 and 106-2628-E-002-003-MY3.References
1. Williams
DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion
using spin inversion of arterial water. Proc Natl Acad Sci USA 1992;89:212-216.
2. Detre JA, W. Zhang,
D.A. Roberts, A.C. Silva, D.S. Williams, D.J. Grandis, A.P. Koretsky, J.S.
Leigh. Tissue specific perfusion imaging using arterial spin labeling. NMR
Biomed 1994;7:75-82.
3. Kim SG.
Quantification of relative cerebral blood flow change by flow-sensitive
alternating inversion recovery (FAIR) technique: application to functional
mapping. Magn Reson Med 1995;34:293-301.
4. Wu WC, St Lawrence
KS, Licht DJ, Wang DJ. Quantification issues in arterial spin labeling
perfusion magnetic resonance imaging. Top Magn Reson Imaging 2010;21(2):65-73.
5. Telischak NA, Detre
JA, Zaharchuk G. Arterial spin labeling MRI: clinical applications in the
brain. Journal of magnetic resonance imaging : JMRI 2015;41(5):1165-1180.
6. Haller S, Zaharchuk
G, Thomas DL, Lovblad KO, Barkhof F, Golay X. Arterial spin labeling perfusion
of the brain: emerging clinical applications. Radiology 2016;281(2):337-356.
7. Alsop DC, Detre JA,
Golay X, Günther M, Hendrikse J, Hernandez-Garcia L, Lu H, MacIntosh BJ, Parkes
LM, Smits M, van Osch MJ, Wang DJ, Wong EC, Zaharchuk G. Recommended
implementation of arterial spin-labeled perfusion MRI for clinical
applications: A consensus of the ISMRM perfusion study group and the European
consortium for ASL in dementia. Magn Reson Med 2015;73(1):102-116.
8. Bokkers RP, Bremmer
JP, van Berckel BN, Lammertsma AA, Hendrikse J, Pluim JP, Kappelle LJ, Boellaard
R, Klijn CJ. Arterial spin labeling perfusion MRI at multiple delay times: a
correlative study with H(2)(15)O positron emission tomography in patients with
symptomatic carotid artery occlusion. J Cereb Blood Flow Metab
2010;30(1):222-229.
9. Parkes LM, Tofts PS.
Improved accuracy of human cerebral blood perfusion measurements using arterial
spin labeling: accounting for capillary water permeability. Magn Reson Med
2002;48(1):27-41.
10. Wu WC, Jiang SF,
Yang SC, Lien SH. Pseudocontinuous arterial spin labeling perfusion magnetic
resonance imaging--a normative study of reproducibility in the human brain.
Neuroimage 2011;56(3):1244-1250.
11. van Laar PJ, van
der Grond J, Hendrikse J. Brain perfusion territory imaging: methods and
clinical applications of selective arterial spin-labeling MR imaging. Radiology
2008;246(2):354-364.
12. van Laar PJ,
Hendrikse J, Klijn CJ, Kappelle LJ, van Osch MJ, van der Grond J. Symptomatic
carotid artery occlusion: flow territories of major brain-feeding arteries.
Radiology 2007;242(2):526-534.
13. Chen YF, Tang SC,
Wu WC, Kao HL, Kuo YS, Yang SC. Alterations of cerebral perfusion in
asymptomatic internal carotid artery steno-occlusive disease. Sci Rep
2017;7(1):1841.
14. Hoge RD, Atkinson
J, Gill B, Crelier GR, Marrett S, Pike GB. Investigation of BOLD signal
dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin
dilution model. Magn Reson Med 1999;42(5):849-863.
15. Blockley NP,
Griffeth VE, Simon AB, Buxton RB. A review of calibrated blood oxygenation
level-dependent (BOLD) methods for the measurement of task-induced changes in
brain oxygen metabolism. NMR Biomed 2013;26(8):987-1003.